Literature DB >> 13172657

Cortisone in the treatment of the oculo-mucous membrane (Stevens-Johnson) syndrome.

B SHALLARD, J M LAYING.   

Abstract

Entities:  

Keywords:  CORTISONE/therapeutic use; ERYTHEMA NODOSUM/therapy

Mesh:

Substances:

Year:  1954        PMID: 13172657      PMCID: PMC1825046     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Stevens-Johnson syndrome.

Authors:  W R HAAS; A BIRENBAUM; C E KAMINESTER
Journal:  U S Armed Forces Med J       Date:  1952-10

2.  Influence of various alcoholic beverages on coronary flow; experiments on isolated rabbit hearts.

Authors:  O VARTIAINEN; E V VENHO; M VAPAAVUORI
Journal:  Ann Med Intern Fenn       Date:  1953

3.  Stevens-Johnson syndrome treated with A.C.T.H.

Authors:  W G D CALDWELL
Journal:  Lancet       Date:  1953-06-06       Impact factor: 79.321

4.  Stevens-Johnson syndrome treated with cortisone and ACTH.

Authors:  G P LANDEGGER
Journal:  Calif Med       Date:  1952-10

5.  Erythema multiforme exudativum (Stevens-Johnson syndrome); report on a patient treated with pituitary adrenocorticotropic hormone.

Authors:  V S WAMMOCK; A A BIEDERMAN; R S JORDAN
Journal:  J Am Med Assoc       Date:  1951-10-13

6.  Erythema multiforme exudativum major (Stevens-Johnson syndrome).

Authors:  D W ASHBY; T LAZAR
Journal:  Lancet       Date:  1951-05-19       Impact factor: 79.321

7.  Topical use of cortisone in erythema multiforme bullosum. Report of a case.

Authors:  H C FISHMAN
Journal:  Calif Med       Date:  1951-05

8.  The ocular-mucous membrane syndrome.

Authors:  H M ROBINSON
Journal:  Med Clin North Am       Date:  1951-03       Impact factor: 5.456

9.  Mucosal Respiratory Syndrome.

Authors:  J H Stanyon; W P Warner
Journal:  Can Med Assoc J       Date:  1945-11       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.